Medical Weight Loss for Muskogee, Oklahoma Residents
Muskogee, Oklahoma residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Muskogee through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Muskogee Residents Choose New Hope Weight Loss
Muskogee patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Oklahoma and beyond since 2020.
From our Costa Mesa, California practice, we provide Muskogee with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Although our clinic is physically in Costa Mesa, California, Muskogee residents receive the same physician-supervised care without leaving Oklahoma. We care for patients throughout downtown Muskogee and the greater Muskogee County area of eastern Oklahoma. Compounded semaglutide and tirzepatide ship directly to your door in Oklahoma, and a licensed physician reviews every plan before anything is prescribed.
For Muskogee residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Muskogee is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Muskogee
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Muskogee
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Muskogee address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Muskogee
Does New Hope Weight Loss treat patients in Muskogee?
Yes. Although the clinic is in Costa Mesa, California, we treat Muskogee, Oklahoma residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Muskogee?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Muskogee address in cold-pack packaging.
What do Muskogee patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Muskogee do you serve?
We serve patients from across Muskogee by telehealth, including downtown Muskogee and the greater Muskogee County area of eastern Oklahoma.
What support is there for side effects for Muskogee patients?
Dr. Sharma starts Muskogee patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Muskogee, Oklahoma by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.